Natus Medical (BABY) Offers Prelim. Q3 Sales; Updates Q4, FY11 Guidance
Tweet
Share
E-mailGet Alerts BABY Hot Sheet
Price: $26.75 --0%
Financial Fact:
Income from operations: 15.24M
Today's EPS Names:
IPDN, alrn, JD, More
Financial Fact:
Income from operations: 15.24M
Today's EPS Names:
IPDN, alrn, JD, More
Join SI Premium – FREE
Natus Medical (Nasdaq: BABY) issues preliminary Q3 sales of $51.5 million, down from prior guidance of $58 million given in July. The Street is looking for sales of $57.88 million.
Sees Q4 adj-EPS of 15 cents, which compares to the Street estimate of 19 cents and is down from prior guidance of 19-20 cents. Sees sales of $65 million, the Street is currently looking for $67.5 million.
Sees FY11 sales of $234 million, down from $236 million previously, and compared to the Street estimate of $242.77 million.
Sees Q4 adj-EPS of 15 cents, which compares to the Street estimate of 19 cents and is down from prior guidance of 19-20 cents. Sees sales of $65 million, the Street is currently looking for $67.5 million.
Sees FY11 sales of $234 million, down from $236 million previously, and compared to the Street estimate of $242.77 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deere & Co. (DE) Tops Q2 EPS by 66c; Cuts net income forecast
- GameStop (GME) Halted on Circuit Breaker, Down 25%
- Walmart first-quarter adjusted earnings beat estimates
Create E-mail Alert Related Categories
Guidance, Hot Guidance, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
